Ziosoft Receives FDA Clearance For CT Brain Perfusion Application

Main Category: IT / Internet / E-mail
Also Included In: Regulatory Affairs / Drug Approvals;  MRI / PET / Ultrasound
Article Date: 13 Jan 2009 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:3 stars

3 (1 votes)


Ziosoft®, Inc., a leader in advanced visualization and analysis software for medical imaging, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its CT brain perfusion application.

The brain perfusion application is a powerful analysis tool used with the Ziostation thin-client system. The software is unique in its ability to provide brain perfusion functionality to clinicians as a thin-client application using standard commercial hardware. This software option aids radiologists in stroke assessment by providing a color map of cerebral blood flow and other perfusion-related parameters from CT images of the brain. The brain perfusion application includes image manipulation tools as well as measurement tools such as cerebral blood volume, blood flow and mean transit time. Ziosoft's brain perfusion application provides radiologists with decision support tools to accurately assess the type and extent of cerebral perfusion disturbance whether viewed in a hospital or at a remote location offering physicians flexibility and efficiency in viewing solutions.

"Because time to reach diagnosis and begin treatment for stroke victims is critical, we are pleased to provide this new brain perfusion application which can be accessed enterprise-wide," said Mark Koeniguer, Ziosoft's chief operating officer. "Results can also be accessed via a standard web-browser through Ziostation Web, demonstrating our commitment to providing clinicians with the most advanced imaging software wherever needed."

About Ziosoft Inc.

Ziosoft, Inc. is a recognized leader in networked advanced visualization and analysis software to benefit physicians, patients, and healthcare specialists. Founded in 1998, Ziosoft is the leading independent advanced visualization company in Japan with over 1800 installed systems. Ziosoft is dedicated to providing intelligent and intuitive clinical tools across the enterprise. Ziosoft is a privately held company with locations in Redwood City, CA and Tokyo, Japan.

Ziosoft Inc.

Article adapted by Medical News Today from original press release.
Visit our it / internet / e-mail section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Ziosoft Inc.. "Ziosoft Receives FDA Clearance For CT Brain Perfusion Application." Medical News Today. MediLexicon, Intl., 13 Jan. 2009. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/135172.php>

APA
Ziosoft Inc.. (2009, January 13). "Ziosoft Receives FDA Clearance For CT Brain Perfusion Application." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/135172.php.

Please note: If no author information is provided, the source is cited instead.


IT / Internet / E-mail

Most Popular Articles



Follow Our IT News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our IT / Internet / E-mail Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »